BusinessGeoVax Reports 2018 First Quarter Financial Results and Development Program UpdatesBy Nasdaq OMXMay 3, 2018, 5:00 PM UTC
BusinessGeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine CongressBy Nasdaq OMXApr 5, 2018, 1:00 PM UTC
BusinessGeoVax to Present at the 2018 ASM Biothreats ConferenceBy Nasdaq OMXJan 31, 2018, 2:00 PM UTC
BusinessGeoVax to Collaborate with the U.S. Naval Research Laboratory On Development of Lassa Fever BiosensorsBy Nasdaq OMXDec 12, 2017, 2:02 PM UTC
